893221

Ranbaxy Inc. — FEI 3003476632

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 4, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)